Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Potential different impact of inhibition of thrombin function and thrombin generation rate for the growth of thrombi formed at site of endothelial injury under blood flow condition.

Ayabe K, Goto S, Oka H, Yabushita H, Nakayama M, Tomita A, Hasebe T, Yokota H, Takagi S, Goto S.

Thromb Res. 2019 Jul;179:121-127. doi: 10.1016/j.thromres.2019.05.007. Epub 2019 May 10.

PMID:
31129447
2.

Spatial distribution of factor Xa, thrombin, and fibrin(ogen) on thrombi at venous shear.

Berny MA, Munnix IC, Auger JM, Schols SE, Cosemans JM, Panizzi P, Bock PE, Watson SP, McCarty OJ, Heemskerk JW.

PLoS One. 2010 Apr 29;5(4):e10415. doi: 10.1371/journal.pone.0010415.

3.

Differential inhibitory action of apixaban on platelet and fibrin components of forming thrombi: Studies with circulating blood and in a platelet-based model of thrombin generation.

Pujadas-Mestres L, Lopez-Vilchez I, Arellano-Rodrigo E, Reverter JC, Lopez-Farre A, Diaz-Ricart M, Badimon JJ, Escolar G.

PLoS One. 2017 Feb 13;12(2):e0171486. doi: 10.1371/journal.pone.0171486. eCollection 2017.

4.

Thrombus growth and embolism on tissue factor-bearing collagen surfaces under flow: role of thrombin with and without fibrin.

Colace TV, Muthard RW, Diamond SL.

Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):1466-76. doi: 10.1161/ATVBAHA.112.249789. Epub 2012 Apr 19.

5.

Rate-limiting roles of the tenase complex of factors VIII and IX in platelet procoagulant activity and formation of platelet-fibrin thrombi under flow.

Swieringa F, Kuijpers MJ, Lamers MM, van der Meijden PE, Heemskerk JW.

Haematologica. 2015 Jun;100(6):748-56. doi: 10.3324/haematol.2014.116863. Epub 2015 Mar 13.

6.
7.

Importance of factor Xa in determining the procoagulant activity of whole-blood clots.

Eisenberg PR, Siegel JE, Abendschein DR, Miletich JP.

J Clin Invest. 1993 May;91(5):1877-83.

8.

Antithrombotic effects of PAR1 and PAR4 antagonists evaluated under flow and static conditions.

Hosokawa K, Ohnishi T, Miura N, Sameshima H, Koide T, Tanaka KA, Maruyama I.

Thromb Res. 2014 Jan;133(1):66-72. doi: 10.1016/j.thromres.2013.10.037. Epub 2013 Oct 31.

PMID:
24268424
9.

Inhibition of protease-activated receptor 4 impairs platelet procoagulant activity during thrombus formation in human blood.

French SL, Arthur JF, Lee H, Nesbitt WS, Andrews RK, Gardiner EE, Hamilton JR.

J Thromb Haemost. 2016 Aug;14(8):1642-54. doi: 10.1111/jth.13293. Epub 2016 Jun 22.

11.

Platelet Control of Fibrin Distribution and Microelasticity in Thrombus Formation Under Flow.

Swieringa F, Baaten CC, Verdoold R, Mastenbroek TG, Rijnveld N, van der Laan KO, Breel EJ, Collins PW, Lancé MD, Henskens YM, Cosemans JM, Heemskerk JW, van der Meijden PE.

Arterioscler Thromb Vasc Biol. 2016 Apr;36(4):692-9. doi: 10.1161/ATVBAHA.115.306537. Epub 2016 Feb 4.

PMID:
26848157
12.

Effect of blood flow on thrombin generation is dependent on the nature of the thrombogenic surface.

Diquélou A, Lemozy S, Dupouy D, Boneu B, Sakariassen K, Cadroy Y.

Blood. 1994 Oct 1;84(7):2206-13.

13.

Inactivation of factor Xa by the synthetic inhibitor DX-9065a causes strong anticoagulant and antiplatelet actions in human blood.

Kaiser B, Jeske W, Walenga JM, Fareed J.

Blood Coagul Fibrinolysis. 1999 Dec;10(8):495-501.

PMID:
10636461
14.

Selective inhibition of factor Xa during thrombolytic therapy markedly improves coronary artery patency in a canine model of coronary thrombosis.

Nicolini FA, Lee P, Malycky JL, Lefkovits J, Kottke-Marchant K, Plow EF, Topol EJ.

Blood Coagul Fibrinolysis. 1996 Jan;7(1):39-48.

PMID:
8845461
15.

Coagulation Factor XI Promotes Distal Platelet Activation and Single Platelet Consumption in the Bloodstream Under Shear Flow.

Zilberman-Rudenko J, Itakura A, Wiesenekker CP, Vetter R, Maas C, Gailani D, Tucker EI, Gruber A, Gerdes C, McCarty OJ.

Arterioscler Thromb Vasc Biol. 2016 Mar;36(3):510-7. doi: 10.1161/ATVBAHA.115.307034. Epub 2016 Jan 14.

16.

Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosis.

Vandendries ER, Hamilton JR, Coughlin SR, Furie B, Furie BC.

Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):288-92. Epub 2006 Dec 26.

17.

Factor VIII contributes to platelet-fibrin thrombus formation via thrombin generation under low shear conditions.

Sugita C, Yamashita A, Moriguchi-Goto S, Furukoji E, Takahashi M, Harada A, Soeda T, Kitazawa T, Hattori K, Tamura S, Asada Y.

Thromb Res. 2009 Nov;124(5):601-7. doi: 10.1016/j.thromres.2009.06.035. Epub 2009 Aug 6.

PMID:
19660789
18.

Efficacy of local inhibition of procoagulant activity associated with small-diameter prosthetic vascular grafts.

Oltrona L, Eisenberg PR, Abendschein DR, Rubin BG.

J Vasc Surg. 1996 Oct;24(4):624-31.

19.

Procoagulant activity on injured arteries and associated thrombi is mediated primarily by the complex of tissue factor and factor VIIa.

Speidel CM, Thornton JD, Meng YY, Eisenberg PR, Edgington TS, Abendschein DR.

Coron Artery Dis. 1996 Jan;7(1):57-62.

PMID:
8773434
20.

Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation.

Hoffman M, Monroe DM, Oliver JA, Roberts HR.

Blood. 1995 Sep 1;86(5):1794-801.

Supplemental Content

Support Center